Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Considers Added Support For Struggling Bioventures

This article was originally published in PharmAsia News

Executive Summary

As part of an effort to provide a boost to the country's bioventure industry, the Japanese government is considering creation of a funding group to help. With the consent of the governing political party, government officials have decided the industry should receive some help in its effort to develop promising new drugs. The organization envisioned would include industry experts to offer management and fundraising advice for the startups. The effort also could include merging funds from a government small business agency with private funds to provide investment capital. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068211

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel